Showing results (191-200 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|December 25, 2019
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in boneNicole A Kohart, Said M Elshafae, Wachirapan Supsahvad, et al.Journal of Bone Oncology|November 1, 2019
Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcomaShuliang Zhao, Yi Su, Jinghao Duan, et al.Journal of Bone Oncology|October 2, 2020
Long non-coding RNA BLACAT1 expedites osteosarcoma cell proliferation, migration and invasion via up-regulating SOX12 through miR-608Xiaotao Chen, Yubao Cui, Yanming MaJournal of Bone Oncology|June 20, 2022
Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: A report of 11 cases in a single centerJiashi Cao, Xing Huang, Na Cui, et al.Journal of Bone Oncology|February 24, 2022
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathwayDong Cao, Shanshan Ge, Mengchun LiJournal of Bone Oncology|February 24, 2022
The Harrington plus reconstruction for pelvic and acetabular metastasesMukai Chimutengwende-Gordon, Ross Coomber, Fidel Peat, et al.Journal of Bone Oncology|February 16, 2022
FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literatureFlorian A Frank, Lukas Gerber, Alexander Cornelius, et al.Journal of Bone Oncology|March 4, 2022
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approvalBenoit Cadieux, Robert Coleman, Pegah Jafarinasabian, et al.Journal of Bone Oncology|March 4, 2022
Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinomaJaqueline Vaz Vanini, Leonardo Kenji Sakaue Koyama, Leandro Luongo de Matos, et al.Journal of Bone Oncology|April 5, 2022
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approachDionna Jacobson, Benoit Cadieux, Celestia S Higano, et al.Pageof 69